Artelo Biosciences, Inc. (NASDAQ:ARTL) Expected to Post Earnings of -$0.06 Per Share

Wall Street analysts expect that Artelo Biosciences, Inc. (NASDAQ:ARTL – Get Rating) will announce earnings of ($0.06) per share for the current fiscal quarter, according to Zacks. Zero analysts have provided estimates for Artelo Biosciences’ earnings. Artelo Biosciences posted earnings per share of ($0.11) during the same quarter last year, which would indicate a positive […]

Related Keywords

Artelo Bioscience ,Artelo Biosciences ,Artelo Biosciences Company Profile Get Rating ,Geode Capital Management ,Virtu Financial ,Zacks Investment Research ,Citadel Advisors ,Nasdaq ,Artelo Biosciences Inc ,Wall Street ,Get Rating ,Investment Research ,Capital Management ,Biosciences Company Profile ,Nasdaq Artl ,Apartl ,Medical ,Ratings ,Consensus ,